- Filed
- Mar 17, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 17, 2025 | 4.89M sh |
| Cash And Equivalents | Q3 2025 · Jan 31, 2025 | $5.58M |
| Cash And Equivalents | Q3 2025 · Apr 30, 2024 | $7.11M |
| Current Liabilities | Q3 2025 · Jan 31, 2025 | $4.7M |
| Current Liabilities | Q3 2025 · Apr 30, 2024 | $3.76M |
| Total Liabilities | Q3 2025 · Jan 31, 2025 | $7.39M |
| Total Liabilities | Q3 2025 · Apr 30, 2024 | $6.14M |
| Current Assets | Q3 2025 · Jan 31, 2025 | $60.66M |
| Current Assets | Q3 2025 · Apr 30, 2024 | $57.44M |
| Total Assets | Q3 2025 · Jan 31, 2025 | $63.72M |
| Total Assets | Q3 2025 · Apr 30, 2024 | $60.78M |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 4.92M sh |
| Shares Diluted | Q3 2025 · Jan 31, 2024 | 4.94M sh |
| Dividends Paid | Q3 2025 · Jan 31, 2024 | $2.91M |
| Capex | Q3 2025 · Jan 31, 2024 | $263K |
| Operating Cash Flow | Q3 2025 · Jan 31, 2024 | $3.99M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $52.71M |
| Stockholders Equity | Q3 2025 · Oct 31, 2023 | $49.49M |
| Stockholders Equity | Q3 2025 · Apr 30, 2023 | $50.65M |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $0.66 |
| Eps Diluted | Q3 2025 · Jan 31, 2024 | $1.13 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $0.66 |
| Eps Basic | Q3 2025 · Jan 31, 2024 | $1.13 |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $396K |
| Sga Expense | Q3 2025 · Jan 31, 2024 | $1.1M |
| Net Income | Q3 2025 · Jan 31, 2024 | $3.24M |
| Net Income | Q3 2025 · Jan 31, 2024 | $5.56M |
| Operating Income | Q3 2025 · Jan 31, 2024 | $1.52M |
| Operating Income | Q3 2025 · Jan 31, 2024 | $4.67M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $2.66M |
| Gross Profit | Q3 2025 · Jan 31, 2024 | $8.03M |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $2.73M |
| Cost Of Revenue | Q3 2025 · Jan 31, 2024 | $8.15M |
| Revenue | Q3 2025 · Jan 31, 2024 | $5.39M |
| Revenue | Q3 2025 · Jan 31, 2024 | $16.18M |